| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 151,938 | 155,801 | 155,639 | 152,879 | | Cost of Revenue | (95,621) | 211,917 | 39,738 | 58,457 | | | Gross Profit | 247,559 | (56,116) | 115,901 | 94,422 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 27,551 | (8,317) | 27,317 | 16,811 | | Non Recurring | 127 |
-
|
-
| 1,963 | | Others | 211,921 | (67,507) | 70,379 | 73,344 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (87,985) | 19,708 | 18,205 | 2,304 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 9,849 | (7,113) | 7,113 | 25,438 | | Earnings Before Interest And Taxes | (87,985) | 12,544 | 25,369 | 38,592 | | Interest Expense | 41,409 | 26,580 | 37,805 | 48,844 | | Income Before Tax | (129,394) | (14,036) | (12,436) | (10,252) | | Income Tax Expense | 14 |
-
| 51 | (9,713) | | Minority Interest | 3,175 |
-
|
-
| 1,463 | | | | Net Income From Continuing Ops | (40,356) | (14,713) | (13,255) | (10,252) | | | Non-recurring Events | | Discontinued Operations | 601 | 2,053 | (168) | (570) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (36,580) | (12,660) | (13,423) | (10,822) | | Preferred Stock And Other Adjustments | (4,196) | (2,198) | (2,006) | (2,800) | | | Net Income Applicable To Common Shares | ($40,776) | ($14,858) | ($15,429) | ($13,622) |
|
0.51% Nasdaq 
Income Statement
